BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17185297)

  • 1. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of an acute bacterial infection with a combination of acetylsalicylic acid/ibuprofen and interferon gamma.
    Hockertz S; Heckenberger R
    Arzneimittelforschung; 1996 Oct; 46(10):1012-5. PubMed ID: 8931897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin and ibuprofen's sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis.
    Eisen DP; McBryde ES; Walduck A
    J Infect Dis; 2013 Dec; 208(11):1925-7. PubMed ID: 23997233
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
    Williams KN; Brickner SJ; Stover CK; Zhu T; Ogden A; Tasneen R; Tyagi S; Grosset JH; Nuermberger EL
    Am J Respir Crit Care Med; 2009 Aug; 180(4):371-6. PubMed ID: 19520903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
    Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
    Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
    El-Ridy MS; Mostafa DM; Shehab A; Nasr EA; Abd El-Alim S
    Int J Pharm; 2007 Feb; 330(1-2):82-8. PubMed ID: 17049192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
    Gangadharam PR; Geeta N; Hsu YY; Wise DL
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
    Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium.
    Dhillon J; Lowrie DB; Mitchison DA
    BMC Infect Dis; 2004 Nov; 4():51. PubMed ID: 15548322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
    Zhang J; Guo M; Huang ZX; Bao R; Yu Q; Dai M; Wang X; Rao Y
    Chin Med J (Engl); 2019 Sep; 132(17):2089-2095. PubMed ID: 31425356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.
    Veziris N; Ibrahim M; Lounis N; Chauffour A; Truffot-Pernot C; Andries K; Jarlier V
    Am J Respir Crit Care Med; 2009 Jan; 179(1):75-9. PubMed ID: 18948422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
    Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
    J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs.
    Lenaerts AJ; Johnson CM; Marrieta KS; Gruppo V; Orme IM
    Int J Antimicrob Agents; 2005 Aug; 26(2):152-8. PubMed ID: 15953708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
    Nakanaga K; Saito H; Ishii N; Goto M
    Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.